Brown Advisory Securities’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-10,000
| Closed | -$370K | – | 152 |
|
2022
Q1 | $370K | Sell |
10,000
-3,000
| -23% | -$111K | 0.22% | 105 |
|
2021
Q4 | $394K | Sell |
13,000
-2,500
| -16% | -$75.8K | 0.17% | 122 |
|
2021
Q3 | $521K | Buy |
15,500
+2,000
| +15% | +$67.2K | 0.15% | 135 |
|
2021
Q2 | $539K | Buy |
13,500
+8,025
| +147% | +$320K | 0.08% | 146 |
|
2021
Q1 | $246K | Buy |
5,475
+300
| +6% | +$13.5K | 0.04% | 214 |
|
2020
Q4 | $293K | Sell |
5,175
-250
| -5% | -$14.2K | 0.05% | 196 |
|
2020
Q3 | $257K | Buy |
5,425
+625
| +13% | +$29.6K | 0.05% | 196 |
|
2020
Q2 | $295K | Hold |
4,800
| – | – | 0.06% | 175 |
|
2020
Q1 | $247K | Hold |
4,800
| – | – | 0.06% | 191 |
|
2019
Q4 | $288K | Hold |
4,800
| – | – | 0.07% | 193 |
|
2019
Q3 | $288K | Hold |
4,800
| – | – | 0.08% | 187 |
|
2019
Q2 | $308K | Sell |
4,800
-300
| -6% | -$19.3K | 0.08% | 186 |
|
2019
Q1 | $411K | Sell |
5,100
-1,051
| -17% | -$84.7K | 0.1% | 185 |
|
2018
Q4 | $330K | Buy |
6,151
+276
| +5% | +$14.8K | 0.06% | 246 |
|
2018
Q3 | $302K | Buy |
5,875
+300
| +5% | +$15.4K | 0.05% | 297 |
|
2018
Q2 | $233K | Sell |
5,575
-100
| -2% | -$4.18K | 0.04% | 331 |
|
2018
Q1 | $249K | Hold |
5,675
| – | – | 0.05% | 309 |
|
2017
Q4 | $285K | Sell |
5,675
-900
| -14% | -$45.2K | 0.06% | 283 |
|
2017
Q3 | $331K | Hold |
6,575
| – | – | 0.07% | 240 |
|
2017
Q2 | $335K | Sell |
6,575
-215
| -3% | -$11K | 0.08% | 235 |
|
2017
Q1 | $272K | Hold |
6,790
| – | – | 0.07% | 251 |
|
2016
Q4 | $324K | Sell |
6,790
-600
| -8% | -$28.6K | 0.09% | 218 |
|
2016
Q3 | $271K | Buy |
+7,390
| New | +$271K | 0.08% | 236 |
|